Literature DB >> 9046646

Spitz naevi misdiagnosed histologically as melanoma: prevalence and clinical profile.

D C Orchard1, J P Dowling, J W Kelly.   

Abstract

A Spitz naevus is a benign melanocytic tumour that may histologically resemble a malignant melanoma. Data was retrospectively gathered from patients who attended the Victorian Melanoma Service to determine the prevalence of Spitz naevi pathologically misdiagnosed as melanoma. Assessment of the clinical characteristics of these patients was also performed and compared to those with correctly diagnosed melanoma. It was found that 6.5% of all melanomas referred were in fact Spitz naevi and that Spitz naevi represented the majority of pathologically misdiagnosed melanomas. The Spitz naevi were more likely to be on the lower extremities and were no average, considerably smaller than the melanomas. Patients with Spitz naevi were more likely to be younger, female, have fewer dysplastic naevi and have brown eyes. One hundred per cent of the Spitz naevi were brought to the attention of the initial doctor by the patient compared to 72% of the melanomas. This study concludes that Spitz naevi that are pathologically misdiagnosed as melanomas retain the clinical characteristics of other Spitz naevi and that greater clinicopathological communication may reduce the frequency of diagnostic error.

Entities:  

Mesh:

Year:  1997        PMID: 9046646     DOI: 10.1111/j.1440-0960.1997.tb01091.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  2 in total

1.  An Epidemiologic Analysis of Melanoma Overdiagnosis in the United States, 1975-2017.

Authors:  Nicholas R Kurtansky; Stephen W Dusza; Allan C Halpern; Rebecca I Hartman; Alan C Geller; Ashfaq A Marghoob; Veronica M Rotemberg; Michael A Marchetti
Journal:  J Invest Dermatol       Date:  2021-12-11       Impact factor: 7.590

Review 2.  Simulants of Malignant Melanoma.

Authors:  Gérald E Piérard; Claudine Piérard-Franchimont; Philippe Delvenne
Journal:  Oncol Rev       Date:  2015-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.